AAPL293.83+4.47 (+1.54%) ▲|ABBV250.91-0.74 (-0.29%) ▼|ABT92.23+1.49 (+1.64%) ▲|ACN131.48+7.04 (+5.66%) ▲|ADBE211.32+6.30 (+3.07%) ▲|AMAT653.06-69.95 (-9.67%) ▼|AMD544.39-36.52 (-6.29%) ▼|AMGN361.22-0.91 (-0.25%) ▼|AMT165.42+1.85 (+1.13%) ▲|AMZN241.80+3.46 (+1.45%) ▲|AVGO371.43-6.33 (-1.67%) ▼|AXP348.39+10.14 (+3.00%) ▲|BA218.90+2.43 (+1.12%) ▲|BAC58.38+1.40 (+2.46%) ▲|BKNG182.65+4.41 (+2.48%) ▲|BLK985.83+24.27 (+2.52%) ▲|BMY56.58-1.04 (-1.81%) ▼|BNY146.43+1.82 (+1.26%) ▲|BRK-B501.32+0.93 (+0.19%) ▲|C140.53+0.57 (+0.41%) ▲|CAT995.21-69.69 (-6.54%) ▼|CL92.40+0.72 (+0.78%) ▲|CMCSA23.74-0.82 (-3.32%) ▼|COF204.58+3.96 (+1.97%) ▲|COP103.35-0.61 (-0.58%) ▼|COST923.50-11.97 (-1.28%) ▼|CRM163.73+7.07 (+4.51%) ▲|CSCO116.84-0.62 (-0.53%) ▼|CVS104.72+1.27 (+1.23%) ▲|CVX165.50-0.26 (-0.16%) ▼|DE630.74-3.59 (-0.57%) ▼|DHR193.93+3.45 (+1.81%) ▲|DIS95.92-0.33 (-0.34%) ▼|DUK125.75-0.83 (-0.66%) ▼|EMR140.02-3.14 (-2.19%) ▼|FDX313.91+0.78 (+0.25%) ▲|GD363.33+9.09 (+2.57%) ▲|GE374.49+0.76 (+0.20%) ▲|GEV1,132.37-42.49 (-3.62%) ▼|GILD126.22-0.12 (-0.10%) ▼|GM75.58-1.50 (-1.95%) ▼|GOOG357.81+4.48 (+1.27%) ▲|GOOGL361.01+3.64 (+1.02%) ▲|GS1,021.36+9.99 (+0.99%) ▲|HD351.43-1.26 (-0.36%) ▼|HON221.77-2.13 (-0.95%) ▼|IBM287.23+6.02 (+2.14%) ▲|INTC127.45-12.18 (-8.72%) ▼|INTU268.67+7.67 (+2.94%) ▲|ISRG400.93+3.25 (+0.82%) ▲|JNJ253.86-0.11 (-0.04%) ▼|JPM333.59+6.26 (+1.91%) ▲|KO81.18-0.09 (-0.11%) ▼|LIN533.18+14.24 (+2.74%) ▲|LLY1,193.00-6.43 (-0.54%) ▼|LMT521.83+12.37 (+2.43%) ▲|LOW221.90+1.41 (+0.64%) ▲|LRCX390.26-43.08 (-9.94%) ▼|MA523.26+9.66 (+1.88%) ▲|MCD269.55-0.76 (-0.28%) ▼|MDLZ58.89+1.05 (+1.82%) ▲|MDT79.26+1.03 (+1.32%) ▲|META612.70+49.41 (+8.77%) ▲|MMM160.51-1.40 (-0.86%) ▼|MO71.38-0.58 (-0.80%) ▼|MRK125.68-2.83 (-2.20%) ▼|MS211.86+2.82 (+1.35%) ▲|MSFT383.80+10.78 (+2.89%) ▲|MU1,047.70-106.59 (-9.23%) ▼|NEE86.66-1.11 (-1.26%) ▼|NFLX74.04+2.64 (+3.69%) ▲|NKE42.93+1.88 (+4.57%) ▲|NOW106.08+6.80 (+6.84%) ▲|NVDA197.97-2.12 (-1.06%) ▼|ORCL143.09-3.46 (-2.36%) ▼|PEP140.51+5.11 (+3.77%) ▲|PFE23.88-0.20 (-0.83%) ▼|PG147.05+0.41 (+0.28%) ▲|PLTR126.08+9.41 (+8.07%) ▲|PM177.08-3.83 (-2.12%) ▼|QCOM183.54-1.25 (-0.68%) ▼|RTX191.21+1.48 (+0.78%) ▲|SBUX102.63+0.44 (+0.43%) ▲|SCHW95.91+3.64 (+3.94%) ▲|SO95.32-0.39 (-0.41%) ▼|SPG222.55-1.11 (-0.49%) ▼|T20.40-0.30 (-1.45%) ▼|TMO514.50+13.14 (+2.62%) ▲|TMUS172.78+5.05 (+3.01%) ▲|TSLA425.70+5.10 (+1.21%) ▲|TXN299.34+1.27 (+0.43%) ▲|UBER72.78+0.62 (+0.85%) ▲|UNH427.38+11.75 (+2.83%) ▲|UNP277.01+5.01 (+1.84%) ▲|UPS109.74+2.24 (+2.08%) ▲|USB62.01+1.61 (+2.66%) ▲|V350.40+7.31 (+2.13%) ▲|VZ41.76-0.58 (-1.37%) ▼|WFC85.69+3.05 (+3.68%) ▲|WMT108.83-4.44 (-3.92%) ▼|XOM135.78-0.94 (-0.69%) ▼|AAPL293.83+4.47 (+1.54%) ▲|ABBV250.91-0.74 (-0.29%) ▼|ABT92.23+1.49 (+1.64%) ▲|ACN131.48+7.04 (+5.66%) ▲|ADBE211.32+6.30 (+3.07%) ▲|AMAT653.06-69.95 (-9.67%) ▼|AMD544.39-36.52 (-6.29%) ▼|AMGN361.22-0.91 (-0.25%) ▼|AMT165.42+1.85 (+1.13%) ▲|AMZN241.80+3.46 (+1.45%) ▲|AVGO371.43-6.33 (-1.67%) ▼|AXP348.39+10.14 (+3.00%) ▲|BA218.90+2.43 (+1.12%) ▲|BAC58.38+1.40 (+2.46%) ▲|BKNG182.65+4.41 (+2.48%) ▲|BLK985.83+24.27 (+2.52%) ▲|BMY56.58-1.04 (-1.81%) ▼|BNY146.43+1.82 (+1.26%) ▲|BRK-B501.32+0.93 (+0.19%) ▲|C140.53+0.57 (+0.41%) ▲|CAT995.21-69.69 (-6.54%) ▼|CL92.40+0.72 (+0.78%) ▲|CMCSA23.74-0.82 (-3.32%) ▼|COF204.58+3.96 (+1.97%) ▲|COP103.35-0.61 (-0.58%) ▼|COST923.50-11.97 (-1.28%) ▼|CRM163.73+7.07 (+4.51%) ▲|CSCO116.84-0.62 (-0.53%) ▼|CVS104.72+1.27 (+1.23%) ▲|CVX165.50-0.26 (-0.16%) ▼|DE630.74-3.59 (-0.57%) ▼|DHR193.93+3.45 (+1.81%) ▲|DIS95.92-0.33 (-0.34%) ▼|DUK125.75-0.83 (-0.66%) ▼|EMR140.02-3.14 (-2.19%) ▼|FDX313.91+0.78 (+0.25%) ▲|GD363.33+9.09 (+2.57%) ▲|GE374.49+0.76 (+0.20%) ▲|GEV1,132.37-42.49 (-3.62%) ▼|GILD126.22-0.12 (-0.10%) ▼|GM75.58-1.50 (-1.95%) ▼|GOOG357.81+4.48 (+1.27%) ▲|GOOGL361.01+3.64 (+1.02%) ▲|GS1,021.36+9.99 (+0.99%) ▲|HD351.43-1.26 (-0.36%) ▼|HON221.77-2.13 (-0.95%) ▼|IBM287.23+6.02 (+2.14%) ▲|INTC127.45-12.18 (-8.72%) ▼|INTU268.67+7.67 (+2.94%) ▲|ISRG400.93+3.25 (+0.82%) ▲|JNJ253.86-0.11 (-0.04%) ▼|JPM333.59+6.26 (+1.91%) ▲|KO81.18-0.09 (-0.11%) ▼|LIN533.18+14.24 (+2.74%) ▲|LLY1,193.00-6.43 (-0.54%) ▼|LMT521.83+12.37 (+2.43%) ▲|LOW221.90+1.41 (+0.64%) ▲|LRCX390.26-43.08 (-9.94%) ▼|MA523.26+9.66 (+1.88%) ▲|MCD269.55-0.76 (-0.28%) ▼|MDLZ58.89+1.05 (+1.82%) ▲|MDT79.26+1.03 (+1.32%) ▲|META612.70+49.41 (+8.77%) ▲|MMM160.51-1.40 (-0.86%) ▼|MO71.38-0.58 (-0.80%) ▼|MRK125.68-2.83 (-2.20%) ▼|MS211.86+2.82 (+1.35%) ▲|MSFT383.80+10.78 (+2.89%) ▲|MU1,047.70-106.59 (-9.23%) ▼|NEE86.66-1.11 (-1.26%) ▼|NFLX74.04+2.64 (+3.69%) ▲|NKE42.93+1.88 (+4.57%) ▲|NOW106.08+6.80 (+6.84%) ▲|NVDA197.97-2.12 (-1.06%) ▼|ORCL143.09-3.46 (-2.36%) ▼|PEP140.51+5.11 (+3.77%) ▲|PFE23.88-0.20 (-0.83%) ▼|PG147.05+0.41 (+0.28%) ▲|PLTR126.08+9.41 (+8.07%) ▲|PM177.08-3.83 (-2.12%) ▼|QCOM183.54-1.25 (-0.68%) ▼|RTX191.21+1.48 (+0.78%) ▲|SBUX102.63+0.44 (+0.43%) ▲|SCHW95.91+3.64 (+3.94%) ▲|SO95.32-0.39 (-0.41%) ▼|SPG222.55-1.11 (-0.49%) ▼|T20.40-0.30 (-1.45%) ▼|TMO514.50+13.14 (+2.62%) ▲|TMUS172.78+5.05 (+3.01%) ▲|TSLA425.70+5.10 (+1.21%) ▲|TXN299.34+1.27 (+0.43%) ▲|UBER72.78+0.62 (+0.85%) ▲|UNH427.38+11.75 (+2.83%) ▲|UNP277.01+5.01 (+1.84%) ▲|UPS109.74+2.24 (+2.08%) ▲|USB62.01+1.61 (+2.66%) ▲|V350.40+7.31 (+2.13%) ▲|VZ41.76-0.58 (-1.37%) ▼|WFC85.69+3.05 (+3.68%) ▲|WMT108.83-4.44 (-3.92%) ▼|XOM135.78-0.94 (-0.69%) ▼|
33.8 C
New York
Wednesday, July 1, 2026

Tag: patient

newssourceFORcompanyinformationcontent1releasesmarket

Rarecells, Inc. Appoints Dr. Rita Shaknovich to Scientific Advisory Board

Rarecells, a leader in liquid biopsy technology, appoints Dr. Rita Shaknovich to its Scientific Advisory Board.

Rewind Therapeutics Strengthens Scientific Advisory Board with Leading International Neurology Experts as it Advances First-in-Class Remyelination Therapy

Professors Shiv Saidha, Cristina Granziera, David Leppert, and Roberto Furlan are world-renowned experts in neuroimaging, multiple sclerosis (MS) biomarkers, neuroimmunology, and translational drug developmentAppointments...

Camurus’ POSITANO study shows treatment effects with CAM2029 in polycystic liver disease patients

CAM2029 reduces liver and cyst volume growth compared to placebo Well tolerated with no new or unexpected safety findingsA follow-up Phase 3 study will be...

Draig Therapeutics Launches with $140 Million (£107 Million) Total Investment to Advance its Portfolio of Next-Generation Therapies for Major Neuropsychiatric Disorders

Cardiff, United Kingdom – 18 June 2025 – Draig Therapeutics (“Draig”), a clinical-stage company aiming to transform the treatment of neuropsychiatric diseases, today launches from stealth having raised a total of $140 million (£107 million) in the last nine months. The oversubscribed Series A financing was led by Access Biotechnology, with participation from Canaan Partners, SR One, Sanofi Ventures, Schroders Capital along with seed investors SV Health Investors, which co-founded the company, and ICG.

Participation in “The 113th Congress of Japan Society of Aesthetic Surgery,” May 2025

～Record Participation for SBC Medical. 22 doctors Present Insights in Their Respective Fields～ 
～Record Participation for SBC Medical. 22 doctors Present Insights in Their Respective Fields～

ZERO Prostate Cancer and Tolmar Launch Groundbreaking “Peaks Challenge” to Spotlight Survivorship and Early Detection

9 Survivors. 11 Advocates. One Mountain. A Life-Changing Mission to Save Lives. ALEXANDRIA, Va., June 17, 2025 /PRNewswire/ -- ZERO Prostate Cancer, the nation's leading...

Caris Life Sciences Announces Pricing of Initial Public Offering

IRVING, Texas, June 17, 2025 /PRNewswire/ -- Caris Life Sciences® (Caris), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced...

Peer-Reviewed Study in Nature Scientific Reports Demonstrates Non-Invasive Fat Reduction Using Alma’s Energy-Based Technology

CAESAREA, Israel, June 18, 2025 /PRNewswire/ -- A newly published, peer-reviewed study in Nature Scientific Reports, part of the prestigious Nature Portfolio, presents compelling clinical...

Schools of Nursing See Enrollment Increases Across Most Program Levels, Signaling Strong Interest in Nursing Careers

PhD Nursing Programs See 11th Year of Enrollment Declines WASHINGTON, June 17, 2025 /PRNewswire/ -- New data released today by the American Association of Colleges...

Chronic Hepatitis B Market–The US to Have the Lion’s Share Among the 7MM, Predicts DelveInsight

The chronic hepatitis B market size is predicted to surge owing to the increasing prevalence of the disease globally and rising awareness about early...

Applied Therapeutics Announces Key Leadership Appointments

NEW YORK, June 17, 2025 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a biopharmaceutical company dedicated to creating transformative treatments for rare disease, today announced key appointments to its executive leadership team with the promotions of Evan Bailey, MD, to Chief Medical Officer (CMO), effective June 15, 2025, and Dottie Caplan to Executive Vice President (EVP), Patient Advocacy and Government Affairs.

Dr. Andrew Gomes Launches New Scholarship to Support U.S. Veteran Undergraduate Students

HOUSTON, June 17, 2025 (GLOBE NEWSWIRE) -- In a powerful show of support for America’s veterans, leading Diagnostic Radiologist Dr. Andrew Gomes has announced the creation of the Dr. Andrew Gomes Scholarship for Veterans, a new opportunity aimed at empowering those who have served in the military and are now pursuing undergraduate degrees. The scholarship, which is awarded through an essay-based application process, is now accepting submissions through March 15, 2026. The winning recipient will be announced on April 15, 2026.

Human Longevity, Inc. Expands Pancreatic Cancer Prevention Commitment with $1 Million Pledge for Qualified Members

SOUTH SAN FRANCISCO, Calif., June 17, 2025 /PRNewswire/ -- Human Longevity, Inc. (HLI), a global leader in precision medicine and proactive health, today announced...

Genomics announces next stage of global roll-out of its predictive clinical tool Health Insights – the first ever UKCA-marked and MHRA registered test that...

Health Insights UK is Genomics' predictive clinical tool. It provides genetic risk testing as a secure, end-to-end solution based on a saliva sample that...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsPatient

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers